CHONGQING LUMMY PHARMACEUTICAL CO., LTD.

Other languages Chongqing Lummy Pharmaceutical Co., Ltd.

Equities

300006

CNE100000H10

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-04 pm EDT			5-day change	1st Jan Change
2.44 ^CNY	+6.09%		+4.27%	-34.41%

Jun. 05	Lummy Pharmaceutical Gets Nod to Market Naloxone Hydrochloride Injection	MT
Apr. 23	Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lummy Pharmaceutical Gets Nod to Market Naloxone Hydrochloride Injection	Jun. 05
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22
Lummy Pharma Gets Nod to Raise Dosage of Gastric Drug	Mar. 18
Lummy Pharma Gets Nod to Market Nicorandil	Mar. 04
Lummy Pharmaceutical's Ramosetron Hydrochloride Injection Passes Regulatory Evaluation	Nov. 10
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-20
Lummy Pharmaceutical's Unit Gets Nod to Trial Ovarian Cancer Drug; Shares Surge 20%	23-09-15
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23
Chongqing Lummy Pharmaceutical's Cancer Drug Passes Regulatory Evaluation	23-07-07
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21
Lummy Pharma Unit Gets Regulatory Nod in China for Liver Cirrhosis Drug	23-01-02
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-30
Chongqing Lummy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-23
Chongqing Lummy Pharmaceutical Co., Ltd. Announces Cash Dividend for the Year 2020	21-04-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Chongqing Lummy Pharmaceutical Co., Ltd.

Equities

300006

CNE100000H10

Other languages

Filters